Latest Technology News

Alexium International has acquired Microtek Laboratories’ microencapsulation and phase-change material business, backed by a $6.8 million entitlement offer to strengthen its manufacturing and innovation capabilities in the US.

Pure Resources Limited has raised $1.7 million through a share placement and option issuance to advance its Garnet Hills graphite project, highlighting promising jumbo flake graphite findings.

4DMedical has gained Canadian regulatory approval for its innovative CT – VQ™ ventilation-perfusion imaging technology, enabling immediate commercial rollout through Philips and expanding its North American footprint.

Metal Bank Limited (MBK) has announced its first formal gold resource estimate at the Seven Leaders Starter Pit, marking a pivotal step towards production in 2026. The 6,300-ounce resource underpins a strategy to leverage existing infrastructure and minimise capital costs.

The ASX has suspended trading of Olympio Metals and Thorney Technologies shares due to delayed periodic report filings, highlighting ongoing compliance challenges for both companies.

Genetic Signatures announces the upcoming departure of CEO Allison Rossiter, initiating a leadership transition as the company intensifies its focus on US market expansion.

Cann Group Limited has successfully completed a significant debt restructure and equity raising, improving its financial footing and liquidity to support future growth.

Diatreme Resources has submitted the Draft Environmental Impact Statement for its Northern Silica Project, marking a significant step toward regulatory approval and highlighting its potential to boost regional economies and support global solar energy growth.

Resolution Minerals appoints Dr Adam Roper as Chief Metallurgist to advance antimony, tungsten, and gold processing at its Idaho Horse Heaven Project, aligning with US defense supply chain goals.

Fortuna Metals has confirmed a significant rutile discovery at its Mkanda project in Malawi, with high-grade drill results reaching up to 2.21% rutile over wide intervals. This discovery, adjacent to a world-class deposit, signals strong potential for a large-scale titanium feedstock resource.

IperionX partners with Carver Pump to fast-track production of critical titanium components for U.S. Navy ships, aiming to cut lead times from over a year to under a week.

Prescient Therapeutics has secured European authorization to initiate a Phase 2a clinical trial of its novel cancer drug PTX-100 for relapsed/refractory Cutaneous T-cell Lymphoma, enabling trial site activation in Italy.